Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>Events

  Events

July 2014
Scientific News
Natural Protein Points to New Inflammation Treatment
Findings may offer insight to effective treatments for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.
Tricked-Out Immune Cells Could Attack Cancer
New cell-engineering technique may lead to precision immunotherapies.
Therapy Halts Progression of Lou Gehrig’s Disease
Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.
Crouching Protein, Hidden Enzyme
A new study led by scientists at The Scripps Research Institute (TSRI) and the University of California (UC), Berkeley shows how a crucial molecular enzyme starts in a tucked-in somersault position and flips out when it encounters the right target.
Utilizing Antibodies from Ebola Survivors
A collaborative team from The University of Texas Medical Branch at Galveston, Vanderbilt University, The Scripps Research Institute and Integral Molecular Inc. have learned that antibodies in the blood of people who have survived a strain of the Ebola virus can kill various types of Ebola.
Engineering Foe into Friend
Bose Grant awardee Jacquin Niles aims to repurpose the malaria parasite for drug delivery.
Important Regulator of Immune System Decoded
Plasma cells play a key role in our immune system. Now scientists at the Research Institute of Molecular Pathology (IMP) in Vienna, Austria, and at the Walter and Eliza Hall Institute (WEHI) in Melbourne, Australia, succeeded in characterizing a central regulator of plasma cell function.
Bacterial Superglue for Faster Vaccine Development
An interdisciplinary team of Oxford University researchers has devised a new technique to speed up the development of novel vaccines.
Enumeral, MD Anderson Enter Into Collaboration
Strategic collaboration aims to discover and develop potentially novel antibodies against specified targets for immunotherapy.
Joint venture for GlycoMar Limited and MicroA AS
Scottish biotechnology company GlycoMar and Norwegian technology company MicroA are pleased to announce their joint venture business Prasinotech Ltd. The new company is registered in Scotland.
Bioplasma World Asia 2014
01 Jul 2014 - 02 Jul 2014
Singapore, Asia
Bioplasma World Asia 2014
More information
Lyophilisation: Pharmaceutical & Biopharmaceutical 2014
07 Jul 2014 - 08 Jul 2014
London, UK
Lyophilisation: Pharmaceutical & Biopharmaceutical 2014
More information
Regulatory Affairs in Biosimilars: EU vs US
09 Jul 2014 - 09 Jul 2014
WEBINAR
Regulatory Affairs in Biosimilars: EU vs US
More information
09 Jul 2014 - 11 Jul 2014
Boston, MA, USA
12th Vaccines Research and Development: All Things Considered 
More information
How to automate the analysis of MS data for biotherapeutics characterization
15 Jul 2014 - 15 Jul 2014
Webinar
How to automate the analysis of MS data for biotherapeutics characterization
More information
21 Jul 2014 - 23 Jul 2014
Las Vegas, NV, USA
3rd International Conference and Exhibition on Food Processing & Technology
More information
International Bioprinting Congress
24 Jul 2014 - 25 Jul 2014
Singapore, Asia
International Bioprinting Congress
More information




SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!